- Stocks in Play
- Posts
- Stocks in Play - October 24th 2025
Stocks in Play - October 24th 2025
Stocks in Play: REKR, INBX, GNTA

Stocks in Play - October 24th 2025
Stocks in Play: REKR, INBX, GNTA
Welcome to today's Stocks in Play report. Below are the key stocks to watch, along with brief x-ray and analysis.
If you find this Newsletter helpful and ever want to say thank you then feel free to Buy Me a Coffee. It’ll inspire me to work faster….
Honorable Mention
INBX: Inhibrx announced positive topline results from the registrational ChonDRAgon trial (n=206) of ozekibart (INBRX-109) in advanced/metastatic chondrosarcoma, a rare bone malignancy with no approved systemic therapy. The trial met its primary endpoint, showing a 52% reduction in risk of progression or death (HR 0.479; p<0.0001), doubling median PFS to 5.52 months vs 2.66 for placebo.
Strong Catalyst. Chart is not neglected on the daily however it is having an IPO Breakout on the weekly. High unmet need. Strong catalyst. Good volume. Potentially an U&R of $50?
X-Ray INBX: Industry Group: Biotechnology, Market Cap: 410.81M, Float: 9.86M Short Interest 5.32%, Days to Cover: 3.47, Exchange: NASDAQ
GNTA: Genenta Science announced an expanded strategic collaboration with Anemocyte to commercialize its off-the-shelf lentiviral vector (LVV) Plasmid DNA platform. This builds upon their existing relationship in plasmid DNA manufacturing. I’m including this as these EU ADRs can go apeshit sometimes. This one hit $40 in the afterhours. Potential for it to do something similar today. Very likely a one day wonder if it does work. Trade with caution.
X-Ray GNTA: Industry Group: Biotechnology, Market Cap: 61.85M, Float: - Short Interest -, Days to Cover: 0.11, Exchange: NASDAQ
REKR: Rekor Systems announced the formation of Rekor Labs, a new subsidiary focused on deepfake detection technology—marking a major diversification beyond its core roadway intelligence business. Rekor Labs aims to commercialize a proprietary AI-driven verification system designed to authenticate video, audio, and image content.
Story theme. AI/Deepfakes/Cybersecurity. I’ve recommended this stock previously. Chart is coming out of a significant downtrend on the weekly. Retesting the Breakout. A push above $3 gets it going. Not neglected on the daily. Highlighting because of theme. Essentially it’s a pullback setup today.
X-Ray REKR: Industry Group: Software - Infrastructure, Market Cap: 334.79M, Float: 120.92M Short Interest 9.68%, Days to Cover: 2.39, Exchange: NASDAQ
Market Awareness
I don’t see anything 5 Star today. I have included some reasonable looking Stocks in Play. I think INTC is not good enough in terms of results to actually go substantially higher. Though there is clearly investor interest.
CPI came in cooler. I’m bullish overall. I think we’re going higher but it’s still important to wait for the best setups. Plenty of stocks left in earnings season. Patience will win out. Don’t use mental capital on substandard setups. When the A+ one hits it’ll be clear as day.
Have a Great Weekend!
Sources & Services I Use in my Trading:
Finviz - Short Interest, Float, Articles, Fundamentals (Free)
Benzinga Pro - News Source + News Squawk + Earnings Data (Paid)
Tradingview - Charting & Scanning (Paid)
Koyfin - Fundamental Data (Paid)
EarningsWhispers - Earnings Calendar (Free)
Tradersync - Trade Journal (Paid)
PS: There are many ways to trade stocks in play. It does not have to be the one that keeps going straight up and sometimes it doesn’t even have to be day one of the catalyst. Everyone must find a setup, timeframe and method that works for them. This list is supposed to educate on the criteria I use and the methods in which I find Stocks in Play. Yours may differ and that is completely okay.
Reply